Karin Hamberg
Director/Board Member at LEO Holding A/S (Denmark)
Profile
Karin Jexner Hamberg is currently a Director at LEO Holding A since 2019.
She was previously the Chief Medical Officer & Executive Vice President at Veloxis Pharmaceuticals A in 2009.
She holds a doctorate degree from the University of Copenhagen.
Karin Hamberg active positions
| Companies | Position | Start |
|---|---|---|
LEO Holding A/S (Denmark)
 LEO Holding A/S (Denmark) Financial ConglomeratesFinance LEO Holding A/S invests in company with interest in medical dermatology. The company was founded on November 29, 2017 and is headquartered in Copenhagen, Denmark. | Director/Board Member | 2019-02-26 |
Former positions of Karin Hamberg
| Companies | Position | End |
|---|---|---|
| VELOXIS PHARMACEUTICALS A/S | Chief Tech/Sci/R&D Officer | 2009-04-14 |
Training of Karin Hamberg
| University of Copenhagen | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Veloxis Pharmaceuticals A/S
 Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Veloxis Pharmaceuticals A/S is a commercial-stage specialty pharmaceutical company, which engages in the development and commercialization of medicine for the prevention of organ rejection in kidney transplant patients. The company is focused on the direct commercialization of Envarsus XR in the US, expansion of partnerships for markets, and acquisition of assets utilized in transplant patients and by adjacent medical specialties. Veloxis Pharmaceuticals was founded in June 2002 and is headquartered in Copenhagen, Denmark. | Health Technology |
LEO Holding A/S (Denmark)
LEO Holding A/S (Denmark) Financial ConglomeratesFinance LEO Holding A/S invests in company with interest in medical dermatology. The company was founded on November 29, 2017 and is headquartered in Copenhagen, Denmark. | Finance |
- Stock Market
- Insiders
- Karin Hamberg
